You are here: Industry Insights > Aptar

News List

Nanopharm, Leyden Labs to Develop Nasal Spray Drugs contractpharma
July 23, 2021
Intranasal spray product candidates will target known and new respiratory viruses.
Pharmaceutical packaging market to value over $144bn by 2027 europeanpharmaceuticalreview
March 16, 2021
New research suggests the use of innovative and development of eco-friendly packaging, as well as the COVID-19 pandemic will all drive growth in the pharmaceutical packaging market.
Aptar Requests EUA for N95 Filtering Facepiece Respirator Decontamination americanpharmaceuticalreview
April 21, 2020
AptarGroup is seeking U.S. FDA Emergency Use Authorization (EUA) for a solution that allows easy disinfecting of N95 filtering facepiece respirators (N95 mask).
Aptar acquires Nanopharm and Gateway Analytical expressbpd
June 14, 2019
Both acquisitions bring complementary, value-added and differentiated analytical, testing and development services for all stages of drug development and commercialisation
Aptar Pharma & Kali Care to develop medication monitoring tech for trials europeanpharmaceuticalreview
May 07, 2019
Aptar Pharma’s dispensing technologies combined with Kali Care’s smart sensors, data analytics and cloud services will make clinical trials more efficient.
Aptar and Propeller Health partner on digital medicines platform pharmaceutical-technology
June 01, 2018
Drug delivery system provider Aptar Pharma has collaborated with local digital therapeutics firm Propeller Health to introduce a comprehensive platform for the development of digital medicines across various therapeutic areas and diseases.